As of 2025-09-17, the Relative Valuation of ImmunoGen Inc (IMGN) is (6.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -121.8%.
The range of the Relative Valuation is (6.10) - (6.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 25.5x | 22.2x |
| Forward P/E multiples | 23.2x - 31.4x | 29.6x |
| Fair Price | (6.10) - (6.70) | (6.81) |
| Upside | -119.5% - -121.5% | -121.8% |
| Date | P/E |